Skip to main content

Day: March 24, 2020

Home BancShares, Inc. Announces Changes to Annual Meeting of Shareholders to be Held on April 16, 2020

CONWAY, Ark., March 24, 2020 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NASDAQ: HOMB) (“Home” or the “Company”), parent company of Centennial Bank (“Centennial”), today announced that due to the emerging public health impact of the COVID-19 pandemic and to support the health and well-being of our shareholders and other stakeholders, the Company has changed the time and location of its Annual Meeting of Shareholders to be held on April 16, 2020.  The Annual Meeting will now be held at 9:00 a.m. (CDT) on April 16, 2020 at the Company’s corporate offices located at 719 Harkrider Street, Conway, Arkansas.  Shareholders who vote their shares by proxy do not need to attend the Annual Meeting.  The Company asks that any shareholders who do plan to attend the meeting please notify the Company at least 24 hours in advance of the meeting by...

Continue reading

Sun BioPharma Provides Business Update and Reports Operating Results for FY2019

Enrollment completed in fourth cohort of Phase 1a/1b trial of SBP-101 in pancreatic cancer; expansion cohort initiatedInterim Phase 1 data presented at ASCO GI meeting demonstrated tolerability and tumor response in metastatic pancreatic cancer treatment-naïve patientsMINNEAPOLIS, March 24, 2020 (GLOBE NEWSWIRE) — Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic cancer, today provides a business update and reports financial results for the year ended December 31, 2019. Sun BioPharma is developing SBP-101, a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance to cell function in multiple tumor types, including pancreatic cancer.“I am delighted with the progress...

Continue reading

Bilia postpones the Annual General Meeting to a later date

The Board of Directors of Bilia AB has today, as a result of the spread of the Corona virus Covid-19, taken the decision to postpone the annual general meeting to a later date. During the time until the annual general meeting the Board of Directors of Bilia will analyse and judge the situation and based on this assess the proposal for the 2019 dividend to the shareholders. Bilia will publish a new invitation to the annual general meeting no later than four weeks prior to the new date. The annual general meeting will be held, at the latest, on June 30 2020 in accordance with existing legislation.Short update around Corona related effectsOut of Bilia’s totally 135 facilities, today nine facilities are closed in line with decisions from governments. These facilities are located in Western Europe, and in Belgium and Luxemburg the majority...

Continue reading

Bilias skjuter upp årsstämman till ett senare datum

Styrelsen i Bilia AB har, till följd av spridning av Coronaviruset Covid-19, fattat beslut om att skjuta upp årsstämman till ett senare datum. Fram till tiden för årsstämman kommer Bilias styrelse att analysera och bedöma situationen för att därefter utvärdera förslaget till utdelning för 2019. Bilia återkommer med ny kallelse till årsstämma senast fyra veckor före det nya datumet. Årsstämman kommer att hållas senast den 30 juni 2020, i enlighet med gällande lagstiftning.Kort uppdatering av Coronarelaterade effekterAv Bilias totalt sett 135 anläggningar är idag nio anläggningar stängda enligt myndigheternas beslut. Dessa anläggningar är belägna Västeuropa och i Belgien och Luxemburg har från denna vecka merparten av våra anställda, cirka 300 personer, permitterats från arbetet. I Sverige och Norge är samtliga 95 respektive 27 anläggningar...

Continue reading

TEN Ltd. Reports Profits for Fourth Quarter and Year End 2019 and Declares Dividend of $0.05 per Common Share

200% Increase in Operating Income before impairments Y-o-Y$208 million Repayment of Debt and Preferred in 2019Very Firm Current Rates – Market Long Fundamentals FavorableInitiating $50 million Stock Buyback ProgramATHENS, Greece, March 24, 2020 (GLOBE NEWSWIRE) — TEN, Ltd. (TEN) (NYSE: TNP) (the “Company”) reports results (unaudited) for the fourth quarter and the year ended December 31, 2019.2019 YEAR RESULTSIn 2019, TEN produced profits of $42.7 million before non-cash impairment charges and positive net income of $15.1 million, a $76 million turnaround from 2018.  Such improvement in profitability was primarily due to the very strong freight market that arose in the fourth quarter of the year, and still the case today, and resulted in voyage revenues reaching $597.5 million.

Continue reading

YANGAROO and the Recording Academy® Renew Multi-Year Agreement

TORONTO, March 24, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (“Yangaroo”, “Company”), (TSX-V: YOO, OTCBB: YOOIF), the software leader in work-flow management and media distribution solutions today announces the signing of a multiyear renewal with the Recording Academy®, the organization behind the Annual GRAMMY Awards®. YANGAROO will continue to provide its digital awards management platform that streamlines every aspect of awards-show management.“Having worked with YANGAROO for many years now, we are thrilled to extend the partnership,” said Rick Engdahl, Chief Information Officer of the Recording Academy. “We look forward to continuing a successful and productive relationship.”“This marks another long-term commitment between the Recording Academy and YANGAROO”, said Gary Moss, President & CEO of YANGAROO Inc.. “Their confidence...

Continue reading

Brunswick Corporation thinks beyond the horizon with its inaugural enterprise-wide Sustainability Report highlighting its ESG commitment

METTAWA, Ill., March 24, 2020 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC), today announced the publication of its first Company-wide Sustainability Report.  Themed “Thinking Beyond the Horizon”, the report is part of the Company’s broad commitment to continually advance  the Environmental, Social and Governance (ESG) performance of its business and leverage its considerable resources and scale to address improvement opportunities important for the future of outdoor recreation and its stakeholders. “We are excited to showcase our sustainability initiatives and successes to the world,” said Dave Foulkes, Brunswick Corporation Chief Executive Officer. “As the leader in the recreational marine industry, we dedicate ourselves to continuously innovating the future of the marine business and consumer experiences.  Brunswick understands...

Continue reading

Reminder: ENGlobal 2019 Year-End Results and Conference Call This Thursday, March 26

Houston, March 24, 2020 (GLOBE NEWSWIRE) — ENGlobal (NASDAQ: ENG), a leading provider of engineered modular solutions, will host a conference call on Thursday, March 26, 2020 at 9:00am EDT to discuss the company’s 2019 financial results, which will be announced at 8:00 am that day.To participate in the conference call, please dial (Toll Free) 844-369-8770 domestically or 862-298-0840 internationally, approximately 5-to-10 minutes before the beginning of the call. The call will also be broadcast live over the Internet and can be accessed at:https://www.webcaster4.com/Webcast/Page/2272/33183The teleconference replay will be available by dialing (Toll Free) 877-481-4010 domestically or 919-882-2331 internationally, referencing conference ID 33183, or by visiting the company’s web site. The replay will be available shortly after the...

Continue reading

Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients with Advanced Urothelial Carcinoma (COAXIN)

HOUSTON, March 24, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that the first patient has been dosed in an investigator-sponsored Phase 1/2 clinical trial of the company’s GAS6/AXL inhibitor AVB-500 in combination with PD-L1 inhibitor avelumab in patients with advanced urothelial carcinoma (UC). The study is being led by Abhishek Tripathi, M.D., Assistant Professor of Medicine, Section of hematology/oncology at the University of Oklahoma Stephenson Cancer Center.“Locally advanced or metastatic urothelial carcinoma is an aggressive cancer with poor long-term survival,” said Dr. Tripathi. “Although immunotherapy results in durable responses in some patients, only a small proportion of patients respond and most eventually progress. Targeting additional mechanisms of immunosuppression...

Continue reading

PunaMusta Media -konserni aloittaa yt-neuvottelut lomautuksista

PUNAMUSTA MEDIA OYJ   SISÄPIIRITIETO    24.3.2020 KLO 14.00PunaMusta Media -konserni käynnistää yhteistoimintaneuvottelut koko henkilöstöään koskevista lomautuksista. Toimenpiteiden taustalla on maailmanlaajuisen koronaviruksen aiheuttamat äkilliset heikennykset mediamarkkinoiden ja painoliiketoimintojen eri segmenttien kysyntään. Yt-neuvottelut koskevat konsernin koko henkilöstöä.Yt-neuvottelujen ensisijaisena tavoitteena on varmistaa konsernin toimintaedellytysten säilyttäminen ja henkilöstön hyvinvoinnin turvaaminen.Neuvottelujen piirissä on noin 650 henkilöä. Mahdolliset sopeuttamistoimenpiteet on suunniteltu toteutettavaksi enintään 90 päivän lomautuksilla työntekijää kohden. Lisäksi neuvotteluissa tarkastellaan mahdollisuutta hakea ratkaisuja muiden työaikaan liittyvien toimenpiteiden kautta. Sopeuttamistoimenpiteissä otetaan huomioon...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.